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While different cytokines are present in varying concentra-
tions throughout the course of the pregnancy, a balance
ensures that the fetus is carried to term. The interleukins
(ILs) assessed in this study included IL-1α, IL-1β, IL-6, IL-8, and
IL-10, while other cytokines, such as tumor necrosis factor
(TNF)-α, C-reactive protein (CRP), and matrix metalloprotei-
nase (MMP)-8, were also measured. While these cytokines
generally play differing roles in the human body, some altera-
tions may be an indicator for other adverse pregnancy out-
comes, and all cytokines can have adverse effects during
pregnancy if their levels are abnormal. IL-1α and IL-1β peak
prior to labor onset,1 while IL-6, IL-8, and IL-10 are all
components of the inflammatory pathway thatmust behalted
to prevent fetal rejection.2–4 CRP is also involved in the
inflammatory process during pregnancy and maternal levels
can be associatedwith fetal growth restrictions and increased
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Abstract Objective To assess differences in cytokine levels in cervicovaginal fluid (CVF) and
serum across trimesters between women with preterm births (PTBs) and full-term
births.
Study Design This multicenter study enrolled 302 women with a singleton gestation.
CVF and serum cytokines, interleukin 1α (IL-1α), IL-1β, IL-6, IL-8, IL-10, C-reactive protein
(CRP), tumor necrosis factor (TNF)-α, and matrix metalloproteinase (MMP)-8, were
measured. Women with at least one cytokine assessment and noted PTB status in their
medical record were retained in the study (N ¼ 272). Data were analyzed using mixed
modeling (main effects of PTBs and time/trimester).
Results For the CVF values of IL-6, IL-8, IL-10, TNF-α, and CRP, and serumMMP-8, those
who delivered preterm had significantly higher values than the full-term group
regardless of trimester. For the serum values of IL-1β, IL-6, and TNF-α, those delivering
preterm had significantly lower values than those delivering full-term regardless of
trimester. For IL-1β in CVF, the cytokine was significantly higher in the PTB group
for second and third trimesters only, relative to the full-term group.
Conclusion For each CVF cytokine that differed by birth status, values were higher for
PTB than term, averaged over trimester. Numerous cytokine profiles varied across
trimesters in women delivering term versus preterm in both CVF and serum.
received
June 12, 2017
accepted after revision
March 24, 2018
DOI https://doi.org/
10.1055/s-0038-1656534.
ISSN 2157-6998.
Copyright © 2018 by Thieme Medical
Publishers, Inc., 333 Seventh Avenue,
New York, NY 10001, USA.
Tel: +1(212) 584-4662.
THIEME
Original Article e113
risk of neonatal complications.5 TNF-α is a multifunctional
cytokine, but its primary role during pregnancy is to terminate
development if the embryo has suffered damages that will
result in abnormal development.6 When this cytokine is
released inappropriately, the embryo can be terminated
even when lacking abnormalities.
Cytokine concentrations change throughout pregnancy.7
Manyof those involvedwith the inflammatoryprocess, includ-
ing IL-1β and IL-8, decrease to protect the fetus during gesta-
tion.8 Other lipopolysaccharide-stimulated cytokines, such as
IL-6 and TNF-α, have shown a significant increase across the
course of pregnancy.8 The mechanisms of these changes are
not well understood, but the phenomenon has been observed
in longitudinal studies.8,9 Cytokine levels during pregnancy
may be specifically linked to precursors to preterm birth. In
particular, the release of inflammatory cytokines, normally in
response to a bacterial infection, accounts for approximately
halfof all pretermbirths.10,11The objective of this studywas to
assess whether there are differences in cytokine levels across
trimesters betweenwomenwithpretermand full-termbirths,
controlling for maternal sociodemographic and personal fac-
tors. A secondary objective was to contrast findings between
cytokine levels obtained from cervicovaginal fluid (CVF) and
those obtained from serum.
Materials and Methods
These data were obtained from a prospective, multicenter
trial of women with singleton pregnancies. The longitudinal
design assessed demographics and outcomes at each trime-
ster of pregnancy. Potential participants were approached
and screened in the first trimester of pregnancy. Exclusion
criteria targeted conditions with significant influence on
immune markers including preexisting diabetes, heart dis-
ease, a medical history of human immunodeficiency virus
(HIV), bacterial vaginosis, sexually transmitted infections,
any autoimmune disease, or positive drug use. The studywas
approved by the Institutional Review Boards at each data
collection site. Written consent was obtained from all parti-
cipants, who were given modest compensation at each
trimester. Women who completed at least one cytokine
assessment were retained in the study (N ¼ 272). Of these,
therewere 257, 234, and 219withmaternal serummeasure-
ments and 242, 217, and 194with CVFmeasurements across
the three trimesters. Cytokines included: IL-1α, IL-1β, IL-6,
IL-8, IL-10, TNF-α, CRP, andMMP-8. Fewer CVF samples were
collected, as about 9% of women did not provide a specimen
due to a medical condition (e.g., vaginal bleeding, reports of
cramping or discomfort) or refusal. The numbers of samples
available for MMP-8 (serum: 185, 164, 150; and CVF: 165,
147, 124, respectively) are lower than other biomarkers, as it
was added at study midpoint. Trimester collection windows
ranged for 6 weeks (8–13, 18–23, and 28–33 weeks) with a
minimum of 4 weeks between collection periods.
Sample Collection and Cytokine Estimation
Clotted blood samples were centrifuged at 2,000 rpm for
10 minutes, and the serum was divided into three aliquots
andstoredat80°C. Sampleswereanalyzedundiluted. ForCVF
specimens, samples were obtained after the speculum was
placed and the cervix visualized. An ectocervical sample was
collected by sweeping the cervix 360 degrees and kept in place
for 30 seconds to maximize saturation. When removing the
swab (source), a vaginal sample was obtained by sweeping
360degrees in the vaginal vault/posterior fornix. The swabwas
thenplaced in theproprietarycontainer,firmlypressedagainst
the inner cryovial wall to ensure maximum seepage of fluid
into the buffer container; and the vial cap was secured. All
serum and CVF specimens had sufficient amount for analysis,
as high-sensitivity assayswere used to detect below-minimum
concentrations. All sampleswere immediately refrigerated and
were transported to the laboratory within 6 hours, where they
were stored at 20°C for a minimum of 24 hours. To further
process, samples were thawed at 4°C and then centrifuged at
3,750 rpm for 15 minutes. For long-term storage, the samples
were split into three aliquots and stored at 80°C. Cytokines
IL-1α, IL-1β, IL-6, IL-8, IL-10, and TNF-α were measured using
multiplex Beadlyte assay (MPXHCYTO-60K-06) on a Luminex
IS-100 (Austin, TX) according to the manufacturer’s recom-
mendations. High-sensitivity testing was used for samples
below minimum detectable concentrations. Singleplex assays
were used for CRP (Millipore, Billerica, MA) and MMP-8 (R&D
Systems, Minneapolis, MN). The dynamic range of the assays
was 50 to 0.016 ng/mL, with a minimum detection concentra-
tion of 0.0012 ng/mL. All cytokine data were generated using
Milliplex Analyst Software.
Statistical Analysis
Consistent with prior research,9 any CVF or serum cytokine
value classifiedasanoutlier (i.e., outsideof 3SDfromthemean)
was excluded from this analysis. The range in number of
excluded values for any given cytokine and trimester was 1
to 11; the average number of omitted values across the cyto-
kines and trimesters was 4.4 (SD ¼ 1.8). Prior to analysis, all
cytokinevalueswere log-transformed (natural logarithm)asan
adjustment for lack of normality in the raw values. Bivariate
analyses, including the two-sample t-test or chi-square test of
association, were used to compare demographic and personal
characteristics between women who experienced preterm
versus full-term births. Repeated-measures mixed modeling
was used to discern differences in cytokine levels by preterm
birth status during pregnancy, using the MIXED procedure in
SAS. This method was chosen as it allowed for the inclusion of
multiple cytokine values per participant (i.e., one for each
trimester theywere assessed), and also permitted the inclusion
of women who did not have all three assessments in the
analysis, whether due to lack of sample, a measure outside
the 3 SD limit, or missed assessments due to preterm birth or
other reasons.
The primary comparison for each mixed model was
between length-of-pregnancy groups (i.e., women with pre-
term and full-term births). Other factors included in the
model were age, race/ethnicity, education, first-trimester
smoking status, and trimester of pregnancy. We also
included the interaction between length-of-pregnancy
group and trimester in the initial models but removed the
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interaction in all but one model (CVF IL-1β) due to lack of
significance of the trimester by group interaction in the full
model. This suggests that for all cytokines, with the exception
of IL-1β in CVF, the pattern of change over the three trime-
sters in average cytokine levels did not differ between the
two length-of-pregnancy groups. On the other hand, signifi-
cant main effects of length-of-pregnancy group or trimester
for some cytokines suggest that there are differences
between the two term groups (averaged over trimester) or
among the trimesters (averaged over term group). Post hoc
pairwise comparisons for significant main or interaction
effects were accomplished using Fisher’s least significant
difference procedure. All analysis was conducted using SASv.
9.4; an α level of 0.05 was used throughout.
Results
Of the 272 women with at least one cytokine measurement
during at least one trimester who also had their length of
pregnancy recorded, 39 had preterm births and the remain-
ing 233 participants had full-term births. No differences in
maternal age, body mass index, parity, race, education,
income, or smoking status were identified between those
who delivered preterm and term (see ►Table 1). Among
those who delivered preterm, the average gestational age at
delivery was 34.3 weeks (SD ¼ 2.7). The vast majority of
deliveries resulted from spontaneous pretermbirth (n ¼ 26).
while others were a result of preterm premature rupture of
membranes (PPROM) or iatrogenic.
CVF Levels across Trimesters by Length-of-Pregnancy
Status
Repeated-measuresmodels showed significantmain effects of
length-of-pregnancy status (i.e., preterm vs. term) averaged
over trimester for IL-6, IL-8, IL-10, TNF-α, and CRP
(see ►Table 2), controlling for maternal age, race, education,
and first trimester smoking status. For each of the cytokines
with significant length-of-pregnancy main effects, the CVF
cytokine levels were elevated in those who delivered preterm
compared with women with full-term pregnancies
(see ►Fig. 1). A significant difference in the change of CVF
IL-1β levelswas noted across pregnancy betweenwomenwho
delivered preterm and term (i.e., significant length-of-preg-
nancy by trimester interaction effect; see ►Fig. 2). Women
who delivered pretermhad significantly elevated levels atmid
and late trimester, compared with those who delivered full-
term; there was no difference in CVF IL-1β between the two
groups during early pregnancy (first trimester). No differences
were detected in IL-1α orMMP-8 by preterm birth status, and
the interaction between trimester and length-of-pregnancy
was not significant for these two cytokines.
The main effect of trimester, regardless of term status,
was significant for the CVF measurements of IL-1α, IL-8, IL-10,
TNF-α, and MMP-8. With the exception of TNF-α, each of these
cytokines increased as pregnancy progressed. For TNF-α, the
leveldecreasedduring thecourseofpregnancy(see►Fig. 3). For
IL-1α, IL-10, and MMP-8, first-trimester measurements were
significantly less than the measurements at both second and
third trimester, while for IL-8 the first-trimester level was
significantly less than only the third trimester. For TNF-α, the
level atfirst trimesterwassignificantlygreater thanboth second
and third trimesters, while second trimester values were also
significantly greater than third.
Serum Levels across Trimesters by Length-of-
Pregnancy Status
Results from the adjusted linear mixed models based on the
serum values showed significant main effects of preterm
birth status regardless of trimester for IL-1β, IL-6, TNF-α, and
MMP-8 (see►Table 2). Serum levels of IL-6, IL-1β, and TNF-α
were significantly lower for those who delivered preterm
relative to full-term deliveries, but MMP-8 was significantly
higher (see ►Fig. 4). A difference in systemic levels of IL-1α,
IL-8, IL-10, or CRP was not observed by preterm birth status.
None of the eight cytokines measured exhibited a significant
preterm status by trimester interaction.
The main effect of trimester, regardless of preterm/full-
term birth, was significant for serum IL-8, TNF-α, and CRP,
but not for the other five cytokines assessed. For IL-8, the
level at second trimester was significantly less than at third
trimester, but the first trimester level did not differ signifi-
cantly fromeither of the later levels (see►Fig. 5). For CRP and
TNF-α, an increase was observed over time; for both cyto-
kines, the first trimester level was significantly less than
Table 1 Comparison of characteristics between length-of-
pregnancy groups, including all women with at least one
cytokine level measured during pregnancy (N ¼ 272)
Preterm
(n ¼ 39)
Full-term
(n ¼ 233)
p
Maternal age,
mean (SD)
26.8 (6.4) 26.6 (5.1) 0.87a
Body mass index,
mean (SD)
26.6 (5.7) 26.5 (6.3) 0.98a
Parity, n (%)
0 15 (44.1%) 123 (55.2%) 0.24
1 9 (26.5%) 47 (21.1%)
2 or more 10 (29.4%) 53 (23.8%)
Race, n (%)
White 28 (75.7%) 176 (75.9%) 0.98
Other 9 (24.3%) 56 (24.1%)
Education, n (%)
Less than high school 3 (7.9%) 33(14.2%) 0.29
High school or above 35 (92.1%) 199 (85.8%)
Income, n (%)
Less than $20,000 13 (35.1%) 63 (23.3%) 0.39
$20,000 or more 24 (64.9%) 160 (71.7%)
First trimester smoking status, n (%)
Smoker 12 (31.6%) 54 (24.0%) 0.32
Nonsmoker 26 (68.4%) 171 (76.0%)
aGroup comparison via two-sample t-test; all other comparisons via
chi-square test of association.
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Table 2 Repeated-measures models for each cytokine with main effects of length-of-pregnancy status and trimester
CVF Serum
n F p n F p
IL-1α
Length-of-pregnancy 226 0.2 0.64 243 3.7 0.054
Trimester 4.6 0.010 1.9 0.15
IL-1β
Length-of-pregnancy 223 11.4 <0.001 240 4.9 0.028
Trimester 4.6 0.011 <0.1 0.99
Length-of-pregnancy  trimester 3.0 0.049 – –
IL-6
Length-of-pregnancy 224 7.3 0.007 242 9.1 0.0028
Trimester 0.6 0.53 0.4 0.69
IL-8
Length-of-pregnancy 227 4.2 0.042 243 1.0 0.32
Trimester 3.1 0.046 3.0 0.049
IL-10
Length-of-pregnancy 225 20.8 <0.001 239 0.5 0.49
Trimester 16.4 <0.001 1.8 0.16
CRP
Length-of-pregnancy 227 7.2 0.0079 234 1.2 0.27
Trimester 2.2 0.11 4.4 0.013
TNF-α
Length-of-pregnancy 226 26.5 <0.001 240 43.1 <0.001
Trimester 10.1 <0.001 9.1 <0.001
MMP-8
Length-of-pregnancy 158 0.2 0.62 180 5.4 0.022
Trimester 3.7 0.027 2.9 0.056
Abbreviations: CRP, C-reactive protein; CVF, cervicovaginal fluid; IL, interleukin; MMP, matrix metalloproteinase; TNF, tumor necrosis factor.
Note: Models adjusted for age, race/ethnicity, education, and first trimester smoking status; only those with complete data on all covariates, and
those with cytokine data at any trimester, are included in the model.
Fig. 1 Mean (95% confidence interval [CI]) untransformed CVF levels among women during pregnancy significantly varying by length of
pregnancy. (a) IL-6, (b) IL-10, (c) CRP, (d) TNF-α.
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both second and third, while for TNF-α the second trimester
level was also significantly less than that of the third
trimester.
Discussion
For each CVF cytokine that differed by length-of-pregnancy
status, values were higher for preterm than full-term births,
averaged over trimester. This included significant differences
in IL-6, IL-8, IL-10, TNF-α, and CRP between women who
delivered preterm versus full-term. This is consistent with
previous research findings on higher levels of CVF IL-8
associated with gestational age,12 spontaneous preterm
birth,13 and, among womenwith preterm labor and without
PPROM, delivery within 7 days.14 One study found no asso-
ciation between CVF IL-8 and cervical shortening at 20 or 24
weeks’ gestation;15 given the difference between this result
and our present findings, changes in IL-8 may be better
detected later in pregnancy, or may be associated with other
symptoms of preterm birth.
A strength of this study is that it is one of the first to
examine cytokines in both serum and CVF across all three
trimesters of pregnancy. Also, studies examining preterm
birth often do not validate smoking status, often due to
feasibility or cost. Our study is also among the first to use
biochemical validation of smoking status (via urine cotinine)
at each time point.
Several studies have found associations between CVF IL-6
and preterm birth. Higher levels of CVF IL-6 were associated
with delivery within 7 days among women with preterm
Fig. 2 Mean (95% CI) untransformed CVF IL-1β levels among women during pregnancy by preterm birth status at each trimester. Repeated-
measures models showed significant elevated levels among women who delivered preterm in both second (t ¼ 2.2; p ¼ 0.029) and third
trimesters (t ¼ 3.9; p < 0.001).
Fig. 3 Mean (95% CI) untransformed CVF levels among women significantly varying during pregnancy by trimester. (a) IL-1α, (b) IL-8, (c) IL-10,
(d) TNF-α, (e) MMP-8.
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labor.14 In a sample of women tested at hospital admission,
CVF IL-6was significantly higher amongwomenwith PPROM
compared with controls, matched for gestational age.16 Like
our investigation, Reyna-Vallasmil et al found CVF IL-6,
measured in the second trimester, was significantly higher
among women who later delivered preterm.17 In contrast, a
study by Cox et al with full-term pregnancies did not
demonstrate CVF IL-6 to be significantly different between
women either in labor or not in labor.18
In congruencewith our findings, CVF CRP was found to be
associated with microbial invasion of the amniotic cavity
(MIAC) in women with PPROM.19 Our findings, however, are
in contrast to those of Cobo et al, who found that CVF TNF-α
was undetectable in over 50% of a sample of women with
PPROM,19 as well as Seong et al, who found no association
between TNF-α and cervical shortening at 20 or 24 weeks’
gestation.15
Dutt et al found that CVF IL-10 was significantly higher in
non-Caucasian than Caucasian women in both the second
and third trimesters of pregnancy.20 In fact, the median CVF
IL-10 levels among Caucasianwomenwere below the level of
detection in each trimester, so it is notable that IL-10 was
associated with preterm birth in the present study, con-
ductedwith amostly Caucasian (75.8%) sample. It is possible
that Dutt et al’s non-Caucasian sample and the present
study’s sample share salient similarities (e.g., lower-than-
average household income, cumulative life stress) which
contribute to higher levels of CVF IL-10 and an association
with preterm birth.
The findings of elevated CVF cytokines, averaged over
trimester, among women who delivered preterm are in con-
trast with serum cytokine values: for these, nearly all of the
cytokines that exhibited a significant difference for the term/
preterm comparisonwere lower for preterm births compared
with term. This is true for IL-1β, IL-6, and TNF-α, when
averaged over trimester. This finding is very intriguing and a
value of the study. Our finding suggests that expression of the
inflammatory response is not consistent across all biologic
pools and, for pregnancy, appears concentrated on the local
cervical reaction when a pathophysiology potentially respon-
sible for preterm birth is present. Only MMP-8 measured in
serumwas higher for preterm than term deliveries. A compo-
site profile of inflammatory mediators may help improve the
prediction for preterm birth and the extent of the response to
an ongoing pathophysiology.
Others have found differences in CVF versus serum cyto-
kine levels relative to preterm birth. Yavari Kia et al found
significant differences and no correlation between serum
and CVF levels of IL-6 among women with preterm uterine
contractions.21 Since elevated inflammatory biomarkers are
thought to indicate higher risk of earlier birth, our findings
concur with Yavari Kia et al’s conclusion that testing for
serum cytokine levels would be not be clinically useful for
predicting preterm birth.
Gillespie et al found that IL-1β, IL-6, and TNF-α increased
from early to late pregnancy among a sample of womenwith
a mean gestational age at delivery of over 39 weeks (SD
¼ 1.0–1.1).22 Other studies, including one by Ferguson et al,
have found a similar trajectory as Gillespie et al for IL-6
(increasing from 20 weeks’ gestation to the end of preg-
nancy).23,24 However, mean values of serum IL-6 were sig-
nificantly higher for women who delivered preterm than
full-term in Ferguson et al’s sample, and there was no
significant difference in serum IL-1β or TNF-α between
length-of-pregnancy groups. Our finding that serum IL-1β,
IL-6, and TNF-α levels were lower, when averaged over
trimester, for women with preterm births than full-term
births may suggest that the women who delivered preterm
Fig. 5 Mean (95% CI) untransformed serum levels among women during pregnancy significantly varying by trimester. (a) IL-8, (b) CRP, (c) TNF-α.
Fig. 4 Mean (95% CI) untransformed serum levels among women during pregnancy significantly varying by length of pregnancy. (a) IL-6,
(b) TNF-α, (c) MMP-8.
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had not yet reached peak levels of these serum cytokines.
Alternatively, it is possible that the women who delivered
preterm may have a different pattern or trajectory of serum
cytokines than Gillespie et al’s sample of women, most of
whom delivered full-term, and Ferguson et al’s sample,
which had a higher proportion of nonsmokers.
There was a significant interaction between preterm
status and trimester for IL-1β only. Women who delivered
preterm had significantly higher CVF IL-1β values at second
and third trimester, compared with full-term births, but
there was no difference between the preterm status groups
during first trimester in CVF IL-1β. One study found associa-
tions between CVF IL-1β and gestational age, active labor,
and, among women with full-term pregnancies, cervical
dilation.12 Other studies, however, found IL-1β to be not
associatedwith cervical length in the second trimester,15 nor
to be an independent predictor of MIAC.19 While CVF IL-1β
may not be associated with specific symptoms of preterm
birth (cervical shortening, MIAC), our findings indicate a
unique difference in CVF IL-1β between women with pre-
term and full-term deliveries.
For the main effect of trimester (averaging term/preterm
groups together), there tended to be an increase in level
over time for CVF cytokine values. This is true for and
consistent with other studies on IL-1α, IL-8,12 IL-10, and
MMP-8. CVF IL-10 also increased over time, which is similar
to Dutt et al’s finding for non-Caucasian, but not for
Caucasian, women.20 However, CVF TNF-α had the opposite
relationship: a decrease over time. This is potentially con-
gruent with earlier findings that CVF TNF-α was undetect-
able for over 50% of a sample of women with PPROM before
34 weeks’ gestation.19 Taken together, it is possible that
TNF-α levels decreased during pregnancy to the point of
going below the threshold of detection for pregnancies
further complicated by PPROM.
The serum values of IL-8, TNF-α, and CRP had similar
patterns over time, with a tendency toward increase in level
over trimester. Earlier studies have found similar trajectories
for serum TNF-α,22,23 but Ferguson et al found a quadratic
trajectory for serum CRP: increasing until 20 weeks’ gesta-
tion, and then decreasing until delivery.23 Our findings also
differ from another study’s result of no significant difference
in serum IL-8 from first to third trimester, though this was
found in a much smaller sample (n ¼ 26).24
Limitations
The study’s limitations include the 6-week data collection
windows in each trimester, which may not account for
individual differences in cytokine expression within the
same 6-week period. Another limitation was attrition that
occurred throughout the trimesters.
Conclusion
This analysis found differences in cytokine levels throughout
pregnancy between women with preterm and full-term
births. For each CVF cytokine that differed by birth status,
values were higher for preterm than term births, averaged
over trimester. Numerous cytokine profiles varied across
trimesters in women delivering term versus preterm in
both CVF and serum. These differences indicate the need
for further research on connections between maternal cyto-
kine profiles and birth outcomes.
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